Acute antibody-mediated rejection after lung transplantation

Thabut, 2010, Survival differences following lung transplantation among US transplant centers, JAMA, 304, 53, 10.1001/jama.2010.885 Christie, 2012, The registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report–2012, J Heart Lung Transplant, 31, 1073, 10.1016/j.healun.2012.08.004 Bhorade, 2009, Immunosuppression for lung transplantation, Proc Am Thorac Soc, 6, 47, 10.1513/pats.200808-096GO Durrbach, 2010, Advances in immunosuppression for renal transplantation, Nat Rev Nephrol, 6, 160, 10.1038/nrneph.2009.233 Jeannet, 1970, Humoral antibodies in renal allotransplantation in man, N Engl J Med, 282, 111, 10.1056/NEJM197001152820301 Jaramillo, 1999, Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation, Transplantation, 67, 1155, 10.1097/00007890-199904270-00012 McKenna, 2000, Anti-HLA antibodies after solid organ transplantation, Transplantation, 69, 319, 10.1097/00007890-200002150-00001 Girnita, 2004, HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection, J Heart Lung Transplant, 23, 1135, 10.1016/j.healun.2003.08.030 Girnita, 2005, HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction, Am J Transplant, 5, 131, 10.1111/j.1600-6143.2004.00650.x Moll, 2005, Humoral rejection of organ allografts, Am J Transplant, 5, 2611, 10.1111/j.1600-6143.2005.01086.x Glanville, 2010, Antibody-mediated rejection in lung transplantation: myth or reality?, J Heart Lung Transplant, 29, 395, 10.1016/j.healun.2010.01.012 Stewart, 2007, Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection, J Heart Lung Transplant, 26, 1229, 10.1016/j.healun.2007.10.017 Frost, 1996, Hyperacute rejection following lung transplantation, Chest, 110, 559, 10.1378/chest.110.2.559 Bittner, 2001, Hyperacute rejection in single lung transplantation–case report of successful management by means of plasmapheresis and antithymocyte globulin treatment, Transplantation, 71, 649, 10.1097/00007890-200103150-00012 Masson, 2007, Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies, J Heart Lung Transplant, 26, 642, 10.1016/j.healun.2007.03.007 Astor, 2005, Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function, J Heart Lung Transplant, 24, 2091, 10.1016/j.healun.2005.05.015 Girnita, 2006, Antibody-mediated rejection in lung transplantation: case reports, Clin Transpl, 508 Astor, 2009, Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation, Am J Transplant, 9, 409, 10.1111/j.1600-6143.2008.02467.x Morrell, 2009, Acute antibody-mediated rejection after lung transplantation, J Heart Lung Transplant, 28, 96, 10.1016/j.healun.2008.09.013 Daoud, 2013, Diagnosis and treatment of antibody mediated rejection in lung transplantation: a retrospective case series, Transpl Immunol, 28, 1, 10.1016/j.trim.2012.11.009 Takemoto, 2004, National conference to assess antibody-mediated rejection in solid organ transplantation, Am J Transplant, 4, 1033, 10.1111/j.1600-6143.2004.00500.x Berry, 2013, Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT, J Heart Lung Transplant, 32, 14, 10.1016/j.healun.2012.11.005 Hachem, 2010, Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation, J Heart Lung Transplant, 29, 973, 10.1016/j.healun.2010.05.006 Yousem, 2012, The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies, Am J Surg Pathol, 36, 987, 10.1097/PAS.0b013e31825197ae Denicola, 2013, Pathologic findings in lung allografts with anti-HLA antibodies, J Heart Lung Transplant, 32, 326, 10.1016/j.healun.2012.11.018 Sis, 2009, Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining, Am J Transplant, 9, 2312, 10.1111/j.1600-6143.2009.02761.x Campos, 2006, Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure, Am J Transplant, 6, 2316, 10.1111/j.1600-6143.2006.01503.x Langan, 2007, Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival, Am J Transplant, 7, 847, 10.1111/j.1600-6143.2006.01691.x Flechner, 2010, The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation, Transplantation, 90, 1486, 10.1097/TP.0b013e3181fdd9b0 DeVos, 2012, Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation, Kidney Int, 82, 598, 10.1038/ki.2012.190 Cunningham, 1997, A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells, Immunology, 91, 458, 10.1046/j.1365-2567.1997.d01-2249.x Shreeniwas, 1996, Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection, Chest, 110, 1143, 10.1378/chest.110.5.1143